1. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells. (1st February 2021) Authors: Sareddy, Gangadhara R.; Pratap, Uday P.; Venkata, Prabhakar Pitta; Zhou, Mei; Alejo, Salvador; Viswanadhapalli, Suryavathi; Tekmal, Rajeshwar R.; Brenner, Andrew J.; Vadlamudi, Ratna K. Journal: Stem cells Issue: Volume 39:Number 5(2021) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXTH-29. INHIBITION OF LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (KDM1A/LSD1) SENSITIZES GLIOBLASTOMA CELLS TO CHEMO AND RADIATION THERAPY. (9th November 2020) Authors: Alejo, Salvador; Palacios, Bridgitte; Venkata, Prabhakar Pitta; Chen, Yihong; He, Yi; Viswanadhapalli, Suryavathi; Pratap, Uday; Zheng, Siyuan; Brenner, Andrew; Vadlamudi, Ratna; Sareddy, Gangadhara Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer. (1st January 2022) Authors: Venkata, Prabhakar Pitta; Chen, Yihong; Alejo, Salvador; He, Yi; Palacios, Bridgitte E.; Loeffel, Ilanna; Liu, Junhao; Pratap, Uday P.; Gray, Gabrielle; Achuthan Pillai, Sureshkumar Mulampurath; Zou, Yi; Lai, Zhao; Suzuki, Takayoshi; Viswanadhapalli, Suryavathi; Palakurthi, Srinath; Tekmal, Rajes... Journal: Cancer letters Issue: Volume 524(2022) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗